These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28179465)

  • 21. Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI.
    Yang CD; Shen Y; Ding FH; Yang ZK; Hu J; Shen WF; Zhang RY; Lu L; Wang XQ
    Cardiovasc Diabetol; 2020 Sep; 19(1):131. PubMed ID: 32878604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of HbA1c and fasting plasma glucose with incident diabetes: Implications for pre-diabetes thresholds in a Japanese population.
    Nakagami T; Tanaka Y; Oya J; Kurita M; Isago C; Hasegawa Y; Ito A; Hirota N; Tsuzura R; Uchigata Y
    Prim Care Diabetes; 2016 Dec; 10(6):407-414. PubMed ID: 27515716
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycemic profile variability: An independent risk factor for diabetic neuropathy in patients with type 2 diabetes.
    Firouzabadi MD; Poopak A; Sheikhy A; Samimi S; Nakhaei P; Firouzabadi FD; Moosaie F; Rabizadeh S; Nakhjavani M; Esteghamati A
    Prim Care Diabetes; 2023 Feb; 17(1):38-42. PubMed ID: 36464622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.
    Wang C; Song J; Ma Z; Yang W; Li C; Zhang X; Hou X; Sun Y; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen L
    PLoS One; 2014; 9(7):e102941. PubMed ID: 25047354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.
    Jun JE; Jin SM; Baek J; Oh S; Hur KY; Lee MS; Lee MK; Kim JH
    Cardiovasc Diabetol; 2015 Jun; 14():70. PubMed ID: 26041130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cause-specific risk of major adverse cardiovascular outcomes and hypoglycemic in patients with type 2 diabetes: a multicenter prospective cohort study.
    Sun B; He F; Sun L; Zhou J; Shen J; Xu J; Wu B; Liu R; Wang X; Xu H; Chen X; Zhou H; Liu Z; Zhang W
    Endocrine; 2019 Jan; 63(1):44-51. PubMed ID: 30121774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Glycemic Variability and Vascular Complications in Type 2 Diabetes: Post Hoc Analysis of the FIELD Study.
    Scott ES; Januszewski AS; O'Connell R; Fulcher G; Scott R; Kesaniemi A; Wu L; Colagiuri S; Keech A; Jenkins AJ
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32766757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycaemic control for painful diabetic peripheral neuropathy is more than fasting plasma glucose and glycated haemoglobin.
    Pai YW; Tang CL; Lin CH; Lin SY; Lee IT; Chang MH
    Diabetes Metab; 2021 Feb; 47(1):101158. PubMed ID: 32413414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Visit-to-visit HbA1c variability is inversely related to baroreflex sensitivity independently of HbA1c value in type 2 diabetes.
    Matsutani D; Sakamoto M; Minato S; Kayama Y; Takeda N; Horiuchi R; Utsunomiya K
    Cardiovasc Diabetol; 2018 Jul; 17(1):100. PubMed ID: 29991356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Size and shape of the associations of glucose, HbA
    Ruijgrok C; Dekker JM; Beulens JW; Brouwer IA; Coupé VMH; Heymans MW; Sijtsma FPC; Mela DJ; Zock PL; Olthof MR; Alssema M
    Diabetologia; 2018 Jan; 61(1):93-100. PubMed ID: 29018885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between serum asprosin and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in the community.
    Xu LX; Yin JH; Liang D; Li P; Xu MG; Shi GL; Wang Y; Yang J
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7569-7575. PubMed ID: 37667933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events.
    Sheng L; Yang G; Chai X; Zhou Y; Sun X; Xing Z
    Front Endocrinol (Lausanne); 2024; 15():1323571. PubMed ID: 38419951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of Visit-to-Visit Fasting Plasma Glucose Variability on the Development of Type 2 Diabetes: A Nationwide Population-Based Cohort Study.
    Kim JA; Lee JS; Chung HS; Roh E; Lee YB; Hong SH; Kim NH; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi KM
    Diabetes Care; 2018 Dec; 41(12):2610-2616. PubMed ID: 30254081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin-1 predicts incident diabetic peripheral neuropathy in Type 2 Diabetes: a cohort study.
    Pek SLT; Lim SC; Ang K; Kwan PY; Tang WE; Sum CF; Tavintharan S
    Eur J Endocrinol; 2020 Apr; 182(4):429-438. PubMed ID: 32061157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HbA1c, fasting plasma glucose and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R.
    Soulimane S; Simon D; Shaw J; Witte D; Zimmet P; Vol S; Borch-Johnsen K; Magliano D; Vistisen D; Balkau B
    Diabetes Res Clin Pract; 2012 Jun; 96(3):392-9. PubMed ID: 21741107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?
    Zoppini G; Verlato G; Targher G; Casati S; Gusson E; Biasi V; Perrone F; Bonora E; Muggeo M
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):334-9. PubMed ID: 18571393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analysis of the related risk factors of diabetic peripheral neuropathy].
    Nie C; Bao HP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):467-9. PubMed ID: 23627032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated haemoglobin A1c but not fasting plasma glucose conveys risk of chronic kidney disease in non-diabetic individuals.
    Koshi T; Sagesaka H; Sato Y; Hirabayashi K; Koike H; Yamauchi K; Nishimura R; Noda M; Yamashita K; Aizawa T
    Diabetes Res Clin Pract; 2018 Dec; 146():233-239. PubMed ID: 30391503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the performance of HbA1c and fasting plasma glucose in identifying dysglycaemic status in Chinese high-risk subjects.
    Du TT; Yin P; Zhang JH; Zhang D; Shi W; Yu XF
    Clin Exp Pharmacol Physiol; 2013 Feb; 40(2):63-8. PubMed ID: 23198814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of haemoglobin A1c to detect impaired fasting glucose or Type 2 diabetes in a United Kingdom community based population.
    Kumaravel B; Bachmann MO; Murray N; Dhatariya K; Fenech M; John WG; Scarpello TJ; Sampson MJ;
    Diabetes Res Clin Pract; 2012 May; 96(2):211-6. PubMed ID: 22257419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.